
Overview
Adelynn Gerstenberger is an Oncologist in Leland, North Carolina. Dr. Gerstenberger has been practicing medicine for over 18 years. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Graduate Institution
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1333 South Dickinson Drive, Suite 200, Leland, NC 28451
1333 South Dickinson Drive, Suite 200, Leland, NC 28451
Novant Health Cancer Institute - New Hanover (Oncology/Hematology)
Andrew Schreiber is a Hematologist and an Oncologist in Wilmington, North Carolina. Dr. Schreiber has been practicing medicine for over 24 years is highly rated in 80 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Novant Health Cancer Institute - Brunswick Forest (Oncology/Hematology)
John Belle is a Hematologist and an Oncologist in Leland, North Carolina. Dr. Belle has been practicing medicine for over 22 years is highly rated in 33 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration.
Novant Health Cancer Institute - New Hanover (Gynecologic Oncology)
Lucybeth Nieves is an Oncologist in Wilmington, North Carolina. Dr. Nieves has been practicing medicine for over 24 years is highly rated in 19 conditions, according to our data. Her top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Gastrostomy.
Frequently Asked Questions about Dr. Adelynn Gerstenberger
How do I make an appointment with Dr. Adelynn Gerstenberger?
You can book an appointment with Dr. Adelynn Gerstenberger by calling their office at 910-667-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Adelynn Gerstenberger a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Adelynn Gerstenberger is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Adelynn Gerstenberger specialize in?
While Dr. Adelynn Gerstenberger is a Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Adelynn Gerstenberger accept my insurance?
Dr. Adelynn Gerstenberger accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 910-667-3000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Gerstenberger isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.


